Agape ATP 2025 Q3 Earnings Narrowed EPS Loss, Widened Net Loss

Generated by AI AgentDaily EarningsReviewed byRodder Shi
Friday, Nov 14, 2025 4:35 am ET1min read
Aime RobotAime Summary

- Agape ATP’s Q3 2025 revenue grew 11.9% to $370,593, led by skincare and wellness, but net loss expanded to $595,370 despite a 92.3% EPS reduction.

- The stock surged 6.15% post-earnings, reflecting investor optimism despite five years of unprofitability and structural profitability challenges.

- Persistent net losses highlight structural challenges in converting revenue growth to profitability, underscoring the need for cost optimization.

- A 30-day post-earnings hold

strategy
yielded 12.5% cumulative gains over three years, though returns lagged broader markets.

Agape ATP (ATPC) reported mixed results in its fiscal 2025 Q3 earnings, with revenue growth contrasting persistent net losses. While the company narrowed its per-share loss to $0.01 from $0.13 year-over-year, its net loss expanded to $595,370, marking a 13.6% deterioration. The stock’s post-earnings rally suggests investor optimism, though the company remains unprofitable for five consecutive years.

Revenue

Agape ATP’s total revenue surged 11.9% year-over-year to $370,593 in 2025 Q3, driven by robust performance in its core business. Skin care and health and wellness constituted the lion’s share of revenue at $369,319, while the green energy segment contributed a modest $1,274. Unallocated expenses remained negligible at $0, underscoring efficient cost management in this category.

Earnings/Net Income

Despite a 92.3% improvement in per-share losses, the company’s net loss widened significantly to $595,370 in 2025 Q3 from $524,039 in 2024 Q3. This reflects structural challenges in converting revenue growth into profitability. The EPS improvement, while positive, masks the broader financial strain, highlighting the need for strategic cost optimization or margin expansion.

Price Action

The stock price of

Agape ATP
has shown notable short-term momentum, climbing 6.15% in the latest trading day, 11.29% over the past week, and 13.11% month-to-date. This upward trajectory suggests investor confidence in the company’s operational resilience, despite its ongoing unprofitability.

Post-Earnings Price Action Review

The strategy of buying Agape ATP (ATPC) shares on the date of its revenue raise and holding for 30 days yielded moderate returns over the past three years. The cumulative gain was 12.5%, with an average annual return of 4.17%. This approach captured some of the stock’s price appreciation following earnings reports, although the returns were modest compared to broader market indices.

CEO Commentary

No CEO commentary or guidance was provided in the available data.

Guidance

No forward-looking guidance was disclosed in the earnings report.

Additional News

(text2img/)

No non-earnings related news was disclosed in the provided content.

Comments



Add a public comment...
No comments

No comments yet